SOFOSBUVIR (SOF) 400mg / VELPATASVIR (VEL) 100mg, tab.
STD
DORASOVE41T
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
11/07/2024, 22:01:12
Former
Code(s):
DORASOVE4T-
6.4.4.2.1 - Pangenotypic direct-acting antiviral combinations
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AP55
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
SOFOSBUVIR (SOF) / VELPATASVIR (VEL)
Therapeutic Action
Fixed-dose combination of a nucleotide analogue NS5B polymerase inhibitor (sofosbuvir) and an HCV NS5A inhibitor (velpatasvir)
Indications
Chronic Hepatitis C (CHC) infection
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
The dosage 200 mg / 50 mg is intended for paediatric use.
Precautions for Use
Contraindicated in pregnancy and breast-feeding.
Storage
Below 25°C